A case of amoxicillin clavulanate drug induced liver injury
| Autor: | Chelsea Heaven, Teresa Holm, Jamie-Lee Rahiri, Mark Sanders |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | New Zealand Medical Student Journal, Vol 0, Iss 34 (2022) |
| Druh dokumentu: | article |
| ISSN: | 1179-3597 1176-5178 |
| DOI: | 10.57129/IISC8583 |
| Popis: | Amoxicillin clavulanate (Augmentin) is one of the most commonly used antibiotics in New Zealand (NZ). There are a number of known adverse effects of this drug, affecting the cutaneous, gastrointestinal, hepatic, and haematologic systems. Hepatic adverse effects, although rare (17 cases per 100,000 patients treated with amoxicillin clavulanate), include drug induced liver injury (DILI). This case of DILI secondary to amoxicillin clavulanate after admission with choledocholithiasis highlights the importance of recognising and treating rare but severe medication adverse effects. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|